Prognostic role of tumoral PDL1 expression and peritumoral FoxP3+ lymphocytes in vulvar melanomas.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Human Pathology

• Publication date

  2018-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.humpath.2017.12.022PMID 29307625
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis.

  2017cited by this paper
• PDL1 expression in desmoplastic melanoma is associated with tumor aggressiveness and progression

  2017cited by this paper
• Checkpoint inhibition for advanced mucosal melanoma

  2017cited by this paper
• Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases

  2016cited by this paper
• The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600.

  2015cited by this paper
• Identification and clinical relevance of PD-L1 expression in primary mucosal malignant melanoma of the head and neck

  2015cited by this paper
• Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis

  2015cited by this paper
• Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases

  2015cited by this paper
• Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer

  2015cited by this paper
• PD-1 blockade induces responses by inhibiting adaptive immune resistance

  2014cited by this paper
• High expression of FOXP3 in primary melanoma is associated with tumour progression

  2014cited by this paper
• R: A language and environment for statistical computing.

  2014cited by this paper
• Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma.

  2013cited by this paper
• Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells

  2013cited by this paper
• Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

  2012cited by this paper
• Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape

  2012cited by this paper
• Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma.

  2012cited by this paper
• The blockade of immune checkpoints in cancer immunotherapy

  2012cited by this paper
• The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis

  2011cited by this paper
• FOXP3+ Cell Density in Primary Tumor Has No Prognostic Impact in Patients with Cutaneous Malignant Melanoma

  2010cited by this paper
• Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma

  2010cited by this paper
• Cancer esearch oenvironment and Immunology ctive Depletion of Foxp 3 + Regulatory T Cells roves Effective Therapeutic Vaccination R inst Established Melanoma

  2010cited by this paper
• Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.

  2010cited by this paper
• Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.

  2009cited by this paper
• Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin’s lymphoma

  2008cited by this paper
• Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma.

  2007cited by this paper
• Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers

  2006cited by this paper
• Blockade of PD‐L1 (B7‐H1) augments human tumor‐specific T cell responses in vitro

  2006cited by this paper
• Human CD4+CD25+ Regulatory T Lymphocytes Inhibit Lipopolysaccharide-Induced Monocyte Survival through a Fas/Fas Ligand-Dependent Mechanism1

  2006cited by this paper
• Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease

  2006cited by this paper
• CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice.

  2005cited by this paper
• Diagnostic utility of p75 neurotrophin receptor (p75NTR) as a marker of breast myoepithelial cells

  2005cited by this paper
• Foxp3 Expressing CD4+CD25high Regulatory T Cells Are Overrepresented in Human Metastatic Melanoma Lymph Nodes and Inhibit the Function of Infiltrating T Cells1

  2004cited by this paper
• Supporting Online Material

  2003cited by this paper
• Malignant melanoma of the vulva in a nationwide, 25‐year study of 219 Swedish females

  1999cited by this paper
• Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.

  1999cited by this paper
• Vulvar melanoma.

  1996cited by this paper
• Aluminium hydroxide granulomas: light and electron microscopic studies and X‐ray microanalysis

  1982cited by this paper

• Research progress of T cells in cholangiocarcinoma

  2025cites this paper
• Prognostic value of immune biomarkers in melanoma loco-regional metastases

  2025cites this paper
• FOXP3, IL-35, and PD-L1 in intra- and peritumoral lymphocytic infiltrate of cutaneous melanomas as an important part of antitumor immunity.

  2025cites this paper
• Immune checkpoint inhibitors in gynecologic oncology: Current status and perspectives

  2025cites this paper
• Tumor‐Infiltrating Lymphocytes in Breast and Female Genital Tract Cancers: Overlooked Potential and Unexplored Frontiers

  2025cites this paper
• Programmed Cell Death Ligand 1 Immunohistochemical Expression and Cutaneous Melanoma: A Controversial Relationship

  2024cites this paper
• The Expression of Forkhead Box P3 T Regulatory Lymphocytes as a Prognostic Factor in Malignant Melanomas

  2024cites this paper
• Tumour necrosis is a valuable histopathological prognostic parameter in melanomas of the vulva and vagina.

  2024cites this paper
• Multimodality treatment of a primary vulvar melanoma in a low resource setting: A case report

  2023cites this paper
• Role of immunotherapy for lymph node positive vulvar melanoma: utilization and outcomes

  2023cites this paper
• Development and validation of an immune-related gene prognostic index for lung adenocarcinoma

  2023cites this paper
• Number of FoxP3+ regulatory T-cells are associated with recurrence in vulvar squamous cell carcinoma

  2022cites this paper
• Cutaneous Melanoma versus Vulvovaginal Melanoma—Risk Factors, Pathogenesis and Comparison of Immunotherapy Efficacy

  2022cites this paper
• Vulvar Malignant Melanoma: A Narrative Review

  2022influential citation
• The clinicopathological significance and relapse predictive role of tumor microenvironment of intrahepatic cholangiocarcinoma after radical surgery

  2022influential citation
• Genetic markers for characterization and prediction of prognosis of melanoma subtypes: a 2021 update.

  2021cites this paper
• Evaluation of treatment, prognostic factors, and survival in 198 vulvar melanoma patients: Implications for clinical practice.

  2021cites this paper
• Nodular primary cutaneous melanoma is associated with PD-L1 expression

  2020cites this paper
• Is There a Place for Immune Checkpoint Inhibitors in Vulvar Neoplasms? A State of the Art Review

  2020cites this paper
• Predictive biomarkers and tumor microenvironment in female genital melanomas: a multi-institutional study of 55 cases

  2019cites this paper
• PD-L1 regulates tumorigenesis and autophagy of ovarian cancer by activating mTORC signaling

  2019cites this paper
• The changes of angiogenesis and immune regulations in stromal microenvironment of cutaneous melanomas.

  2019cites this paper
• Vulvar Melanocytic Lesions

  2019cites this paper